🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Community-acquired pneumonia (CAP) is often complicated by elevation of car...
Status
Unknown
Location
Sapienza University of Rome
Start Date
2021-01-10
Trial ID
NCT03745664
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of rocatin...
Status
Completed
Location
Cahaba Dermatology and Skin Health Center
Start Date
2023-04-20
Trial ID
NCT05704738
Treatments Being Tested
Primary study objective: To confirm the efficacy of HBM9161 subcutaneous in...
Status
Completed
Location
Huashan Hospital, Fudan University
Start Date
2021-09-25
Trial ID
NCT05039190
Treatments Being Tested
Human recombinant interleukin-2 (rhIL-2) is a biological signalling protein...
Status
Completed
Location
Service d'Endocrinologie Pédiatrique
Start Date
2013-06-27
Trial ID
NCT01862120
Treatments Being Tested
Liraglutide is a glucose-like peptide 1 agonist, currently used as an effec...
Status
Unknown
Location
Multiple Locations
Start Date
2020-04-01
Trial ID
NCT04008290
Treatments Being Tested
This is a multi-center, randomized, double blind, placebo-controlled phase ...
Status
Completed
Location
Peking University People's hospital
Start Date
2022-04-22
Trial ID
NCT05265923
Female inability to conceive a child. The purpose of this prospective rando...
Status
Completed
Location
Centrum voor Reproductieve Geneeskunde
Start Date
2019-05-01
Trial ID
NCT03677336
The purpose of this study is to assess the Pharmacokinetics/Pharmacodynamic...
Status
Completed
Location
Q-Pharm Clinics, Royal Brisbane and Women's Hospital
Start Date
2011-12
Trial ID
NCT01507077
Treatments Being Tested
The primary objective of the study is to determine if Serostim® 4 mg admini...
Status
Completed
Location
University of Alabama/Birmingham
Start Date
2004-05-28
Trial ID
NCT00082628
Treatments Being Tested
This was a four month dose ranging study followed by a 24 to 48 month exten...
Status
Terminated
Location
Anasazi Internal Medicine
Start Date
2009-04
Trial ID
NCT00900146
Treatments Being Tested